Enfusion

Enfusion R&D per Employee

Delisted

The R&D Spending per Employee of Enfusion (ENFN) as of Nov 7, 2026 is 23,383.20 USD. In the previous year, R&D Spending per Employee was 17,404.20 USD — a change of 34.35% (higher).

R&D per Employee

23,383.20USD

YoY

34.35%

Last updated:

R&D Spending per Employee of Enfusion is 2024 23,383.20 USD. R&D Spending per Employee of Enfusion was 2023 17,404.20 USD. It decreases by 34.35% higher compared to the previous year.

The Enfusion R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
3,627.30 USD
Jan 1, 2020
5,527.56 USD
Jan 1, 2021
134,208.22 USD
Jan 1, 2022
15,015.75 USD
Jan 1, 2023
17,404.20 USD
Jan 1, 2024
23,383.20 USD
The Enfusion R&D per Employee history
YEARR&D per EmployeeYoY
23,383.20USD+34.35%
17,404.20USD+15.91%
15,015.75USD-88.81%
134,208.22USD+2,327.98%
5,527.56USD+52.39%
3,627.30USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

R&D Spending per Employee of Enfusion is 23,383.20 USD in 2024.

R&D Spending per Employee of Enfusion changed from 17,404.20 USD to 23,383.20 USD, representing a 34.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Enfusion since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Enfusion

All Key Metrics — Enfusion